Graham Capital Management L.P. Invests $463,000 in Pediatrix Medical Group, Inc. (NYSE:MD)

Graham Capital Management L.P. purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 35,299 shares of the company’s stock, valued at approximately $463,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Deutsche Bank AG increased its holdings in Pediatrix Medical Group by 53.1% during the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company’s stock valued at $971,000 after buying an additional 25,663 shares during the period. Bridgeway Capital Management LLC boosted its position in Pediatrix Medical Group by 2.6% in the fourth quarter. Bridgeway Capital Management LLC now owns 545,445 shares of the company’s stock valued at $7,156,000 after buying an additional 13,607 shares during the last quarter. Bayesian Capital Management LP acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter worth $190,000. BNP Paribas Financial Markets raised its stake in shares of Pediatrix Medical Group by 87.8% during the 4th quarter. BNP Paribas Financial Markets now owns 34,776 shares of the company’s stock valued at $456,000 after buying an additional 16,256 shares during the last quarter. Finally, ArrowMark Colorado Holdings LLC raised its position in Pediatrix Medical Group by 1.9% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 802,898 shares of the company’s stock valued at $10,534,000 after acquiring an additional 15,249 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. UBS Group decreased their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a research report on Monday. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Truist Financial lowered their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 11th. Finally, Macquarie increased their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus target price of $16.67.

Pediatrix Medical Group Stock Up 4.2%

Shares of NYSE:MD opened at $14.79 on Friday. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The firm’s 50-day moving average is $13.69 and its two-hundred day moving average is $14.08. The firm has a market capitalization of $1.27 billion, a PE ratio of -12.32, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. During the same quarter last year, the company earned $0.20 EPS. Pediatrix Medical Group’s revenue for the quarter was down 7.4% compared to the same quarter last year. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.